Blood Cancer

Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers

Physician’s Briefing

Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers

3 hours ago

1 min read

Oral Vitamin C Active in Clonal Cytopenia of Undetermined Significance

Physician’s Briefing

Oral Vitamin C Active in Clonal Cytopenia of Undetermined Significance

21 Sep 2026

1 min read

EHA: Adding Pirtobrutinib to Venetoclax-Rituximab Ups PFS in Chronic Lymphocytic Leukemia

Physician’s Briefing

EHA: Adding Pirtobrutinib to Venetoclax-Rituximab Ups PFS in Chronic Lymphocytic Leukemia

02 Jul 2026

2 min read

Read More

Clinical Briefing Report

clinicalbriefingreport.com